OBJECTIVE: To examine the relationship between endometrial thickness and outcome of medicated frozen-thawed embryo replacement (FER) cycles. DESIGN: A retrospective observational study. SETTING: Assisted conception unit at a university hospital. PATIENT(S): All patients who underwent an FER cycle between 1997 and April 2006 and met the inclusion criteria. INTERVENTION(S): For endometrial preparation, a daily dose of 6 mg of oral E(2) valerate was started on menstrual day 1, and P pessaries (800 mg daily) were administrated when the endometrial thickness had reached 7 mm or more, with ET taking place 2-3 days later. The FER cycles were categorized according to endometrial thickness measurement on the day of P supplementation. MAIN OUTCOME MEASURE(S): Implantation, clinical pregnancy, ongoing pregnancy, and live birth rates. RESULT(S): In all, 768 consecutive medicated FER cycles were analyzed. The lowest pregnancy rates were associated with endometrial thickness <7 mm (n = 13) and >14 mm (n = 12; 7% in both groups). Significantly higher implantation (19% vs. 12%), clinical pregnancy (30% vs. 18%), ongoing pregnancy (27% vs. 16%), and live birth (25% vs. 14%) rates were achieved in cycles where endometrial thickness was 9-14 mm (n = 386), compared with those in which endometrial thickness was 7-8 mm (n = 357). These differences remained significant after adjusting for confounding variables (adjusted odds ratio [OR] = 1.83 [confidence interval {CI} = 1.3-2.6] for clinical pregnancy, 1.8 [CI = 1.2-2.6] for ongoing pregnancy and 1.9 [CI = 1.3-2.8] for live birth). CONCLUSION(S): In medicated FER cycles, an endometrial thickness of 9-14 mm measured on the day of P supplementation is associated with higher implantation and pregnancy rates compared with an endometrial thickness of 7-8 mm.
OBJECTIVE: To examine the relationship between endometrial thickness and outcome of medicated frozen-thawed embryo replacement (FER) cycles. DESIGN: A retrospective observational study. SETTING: Assisted conception unit at a university hospital. PATIENT(S): All patients who underwent an FER cycle between 1997 and April 2006 and met the inclusion criteria. INTERVENTION(S): For endometrial preparation, a daily dose of 6 mg of oral E(2) valerate was started on menstrual day 1, and P pessaries (800 mg daily) were administrated when the endometrial thickness had reached 7 mm or more, with ET taking place 2-3 days later. The FER cycles were categorized according to endometrial thickness measurement on the day of P supplementation. MAIN OUTCOME MEASURE(S): Implantation, clinical pregnancy, ongoing pregnancy, and live birth rates. RESULT(S): In all, 768 consecutive medicated FER cycles were analyzed. The lowest pregnancy rates were associated with endometrial thickness <7 mm (n = 13) and >14 mm (n = 12; 7% in both groups). Significantly higher implantation (19% vs. 12%), clinical pregnancy (30% vs. 18%), ongoing pregnancy (27% vs. 16%), and live birth (25% vs. 14%) rates were achieved in cycles where endometrial thickness was 9-14 mm (n = 386), compared with those in which endometrial thickness was 7-8 mm (n = 357). These differences remained significant after adjusting for confounding variables (adjusted odds ratio [OR] = 1.83 [confidence interval {CI} = 1.3-2.6] for clinical pregnancy, 1.8 [CI = 1.2-2.6] for ongoing pregnancy and 1.9 [CI = 1.3-2.8] for live birth). CONCLUSION(S): In medicated FER cycles, an endometrial thickness of 9-14 mm measured on the day of P supplementation is associated with higher implantation and pregnancy rates compared with an endometrial thickness of 7-8 mm.
Authors: E R Groenewoud; B J Cohlen; A Al-Oraiby; E A Brinkhuis; F J M Broekmans; J P de Bruin; G van den Dool; K Fleisher; J Friederich; M Goddijn; A Hoek; D A Hoozemans; E M Kaaijk; C A M Koks; J S E Laven; P J Q van der Linden; A P Manger; E Slappendel; T Spinder; B J Kollen; N S Macklon Journal: Hum Reprod Date: 2016-05-13 Impact factor: 6.918
Authors: Daniel J Kaser; Stacey A Missmer; Katharine F Correia; S Temel Ceyhan; Mark D Hornstein; Catherine Racowsky Journal: J Assist Reprod Genet Date: 2013-07-04 Impact factor: 3.412